Skip to main content
. 2021 Dec 1;9(12):1811. doi: 10.3390/biomedicines9121811

Figure 4.

Figure 4

Kaplan–Meier progression-free survival (PFS) curves, showing the differences in the survival intervals of MM patients with high levels of i-tRF-GlyGCC (A), and 3′-tRF-LeuAAG/TAG (B), compared to patients with lower levels of these molecules.